Dividend currency election form for the interim dividend for the six months ended 30 June 2026
Filed with HKEX · Stock code 3320 · · 1 page · English and Chinese
If you are in any doubt as to any aspect of this document or as to the action to be taken, you should consult your stockbroker or other registered dealer in securities, bank manager, solicitor, professional accountant or other professional adviser. 閣下如對文件任何内容或應據取之行動有疑問,應諮詢。閣下之股票紀錄或其他注註證券交易商、銀行理理、律師、專業會計師或其他專業藥質問。 華潤醫藥集團有限公司 (Incorporated in Hong Kong with limited liability) (於香港註冊成立的有限公司) DIVIDEND
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
- Announcement unaudited financial results of jiangzhong pharmaceutical for the six months ended 30 June 2021
- China Resources Pharmaceutical Group: Unaudited financial results of cr pharmaceutical holdings for the three months ended 31 March 2021 in relation to issuances of corporate bonds and medium term notes in the prc
- Announcement unaudited financial results of cr sanjiu for the three months ended 31 March 2021
- Announcement unaudited financial results of dong-e-e-jiao for the three months ended 31 March 2021
Later from China Resources Pharmaceutical
- Interim Report 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Inside information potential issuance of shares by CR pharmaceutical commercial
- Inside information completion of the public issuance of the second tranche of 2026 corporate bonds in the PRC
- Inside information completion of the issue of the third tranche of the medium term notes 2026 in the prc
Follow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical